2022
DOI: 10.1101/2022.04.15.22273511
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Novel CSF biomarkers of GLUT1 deficiency syndrome: implications beyond the brain’s energy deficit

Abstract: We used next-generation metabolic screening to identify new biomarkers for improved diagnosis and pathophysiological understanding of glucose transporter type 1 deficiency syndrome (GLUT1DS), comparing metabolic CSF profiles from 11 patients to those of 116 controls. This confirmed decreased CSF glucose and lactate levels in patients with GLUT1DS and increased glutamine at group level. We identified three novel biomarkers significantly decreased in patients, namely gluconic + galactonic acid, xylose-α1-3-gluco… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…The findings in subject 2 may indicate that her brain suffers from a problem that cannot be solved by offering carbohydrates (breakfast) or alternative energy sources (lactate or ketone bodies), and as such confirm that additional cellular abnormalities, on top of the chronic energy failure, may contribute to the underlying disease mechanisms of GLUT1DS. 30 31 32 33 …”
Section: Discussionmentioning
confidence: 99%
“…The findings in subject 2 may indicate that her brain suffers from a problem that cannot be solved by offering carbohydrates (breakfast) or alternative energy sources (lactate or ketone bodies), and as such confirm that additional cellular abnormalities, on top of the chronic energy failure, may contribute to the underlying disease mechanisms of GLUT1DS. 30 31 32 33 …”
Section: Discussionmentioning
confidence: 99%